Cargando…

A Case of Eosinophilic Angiocentric Fibrosis With Palatal Fistulas

Eosinophilic angiocentric fibrosis (EAF) is a rare, but benign, tumefactive lesion of the head and neck regions. It was initially discovered in 1983 but has recently been connected to the spectrum of immunoglobulin G4-related disease (IgG4-RD). It commonly presents with symptoms of nasal obstruction...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadam, Vaibhav R, Vaughn, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712032/
https://www.ncbi.nlm.nih.gov/pubmed/36465730
http://dx.doi.org/10.7759/cureus.30938
_version_ 1784841709024182272
author Kadam, Vaibhav R
Vaughn, Andrew
author_facet Kadam, Vaibhav R
Vaughn, Andrew
author_sort Kadam, Vaibhav R
collection PubMed
description Eosinophilic angiocentric fibrosis (EAF) is a rare, but benign, tumefactive lesion of the head and neck regions. It was initially discovered in 1983 but has recently been connected to the spectrum of immunoglobulin G4-related disease (IgG4-RD). It commonly presents with symptoms of nasal obstruction, structural deformities of the external nose, and involvement of the nasal septum and lateral nasal wall. Our patient presented with a saddle nose deformity, a septal perforation, and palatal fistulas. Laboratory testing for EAF is often negative for the presence of antinuclear cytoplasmic antibodies (ANCA). A definitive diagnosis of EAF can be made through histopathological analysis of the lesion. The appearance of "onion-skin" fibrosis with perivascular infiltration of primary eosinophils is pathognomonic for EAF. While there is a presence of ulceration tissue, EAF does not have any histological signs of necrosis. EAF is a very uncommon etiology of nasal obstructive symptoms; therefore, it is necessary to rule out more conventional pathologies. Even though it appears as a malignant process, it has an excellent prognosis. The common treatment modalities for an active lesion of EAF involve either surgical resection of margins alone or a combination of corticosteroids and resection. Rituximab has also shown benefits in the management of IgG4-RD as a corticosteroid-sparing treatment. Rituximab was chosen for treatment in our patient because surgical resection was not possible due to the absence of an active lesion. In this article, we provide a brief review of EAF and provide a unique case of EAF presenting with oronasal palatal fistulas.
format Online
Article
Text
id pubmed-9712032
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-97120322022-12-02 A Case of Eosinophilic Angiocentric Fibrosis With Palatal Fistulas Kadam, Vaibhav R Vaughn, Andrew Cureus Otolaryngology Eosinophilic angiocentric fibrosis (EAF) is a rare, but benign, tumefactive lesion of the head and neck regions. It was initially discovered in 1983 but has recently been connected to the spectrum of immunoglobulin G4-related disease (IgG4-RD). It commonly presents with symptoms of nasal obstruction, structural deformities of the external nose, and involvement of the nasal septum and lateral nasal wall. Our patient presented with a saddle nose deformity, a septal perforation, and palatal fistulas. Laboratory testing for EAF is often negative for the presence of antinuclear cytoplasmic antibodies (ANCA). A definitive diagnosis of EAF can be made through histopathological analysis of the lesion. The appearance of "onion-skin" fibrosis with perivascular infiltration of primary eosinophils is pathognomonic for EAF. While there is a presence of ulceration tissue, EAF does not have any histological signs of necrosis. EAF is a very uncommon etiology of nasal obstructive symptoms; therefore, it is necessary to rule out more conventional pathologies. Even though it appears as a malignant process, it has an excellent prognosis. The common treatment modalities for an active lesion of EAF involve either surgical resection of margins alone or a combination of corticosteroids and resection. Rituximab has also shown benefits in the management of IgG4-RD as a corticosteroid-sparing treatment. Rituximab was chosen for treatment in our patient because surgical resection was not possible due to the absence of an active lesion. In this article, we provide a brief review of EAF and provide a unique case of EAF presenting with oronasal palatal fistulas. Cureus 2022-10-31 /pmc/articles/PMC9712032/ /pubmed/36465730 http://dx.doi.org/10.7759/cureus.30938 Text en Copyright © 2022, Kadam et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Otolaryngology
Kadam, Vaibhav R
Vaughn, Andrew
A Case of Eosinophilic Angiocentric Fibrosis With Palatal Fistulas
title A Case of Eosinophilic Angiocentric Fibrosis With Palatal Fistulas
title_full A Case of Eosinophilic Angiocentric Fibrosis With Palatal Fistulas
title_fullStr A Case of Eosinophilic Angiocentric Fibrosis With Palatal Fistulas
title_full_unstemmed A Case of Eosinophilic Angiocentric Fibrosis With Palatal Fistulas
title_short A Case of Eosinophilic Angiocentric Fibrosis With Palatal Fistulas
title_sort case of eosinophilic angiocentric fibrosis with palatal fistulas
topic Otolaryngology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712032/
https://www.ncbi.nlm.nih.gov/pubmed/36465730
http://dx.doi.org/10.7759/cureus.30938
work_keys_str_mv AT kadamvaibhavr acaseofeosinophilicangiocentricfibrosiswithpalatalfistulas
AT vaughnandrew acaseofeosinophilicangiocentricfibrosiswithpalatalfistulas
AT kadamvaibhavr caseofeosinophilicangiocentricfibrosiswithpalatalfistulas
AT vaughnandrew caseofeosinophilicangiocentricfibrosiswithpalatalfistulas